相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification
Claire J. Schwab et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials
Amir Enshaei et al.
Lancet Haematology (2021)
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions
Gloria Paz Contreras Yametti et al.
CANCERS (2021)
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia
Amir Enshaei et al.
BLOOD (2020)
Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia
Joanna Zawitkowska et al.
SCIENTIFIC REPORTS (2020)
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Elisabeth M. P. Steeghs et al.
SCIENTIFIC REPORTS (2019)
Comparison between flow cytometry and standard PCR in the evaluation of MRD in children with acute lymphoblastic leukemia treated with the GBTLI LLA-2009 protocol
Juliana Maria Camargos Rocha et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2019)
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
Lina Hamadeh et al.
BLOOD ADVANCES (2019)
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia
N. Toft et al.
LEUKEMIA (2018)
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Martin Stanulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group
Kenichi Sakamoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
David O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
Lynda M. Vrooman et al.
BLOOD ADVANCES (2018)
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children
Rosemary Sutton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
J. M. Boer et al.
LEUKEMIA (2016)
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003
Jack Bartram et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Anja Moericke et al.
BLOOD (2016)
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
Rob Pieters et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
Lynda M. Vrooman et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2016)
Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine
Stephen P. Hunger et al.
BLOOD (2015)
The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013
Linda Olsson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951
E. Clappier et al.
LEUKEMIA (2015)
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia
Anthony V. Moorman et al.
BLOOD (2014)
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002
Jan Stary et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL
Arian van der Veer et al.
BLOOD (2013)
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
Petra Dorge et al.
HAEMATOLOGICA (2013)
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Chiara Palmi et al.
HAEMATOLOGICA (2013)
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
Ajay Vora et al.
LANCET ONCOLOGY (2013)
IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia
Yuka Yamashita et al.
PEDIATRIC BLOOD & CANCER (2013)
Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease
Mawar Karsa et al.
PLOS ONE (2013)
IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
Daisuke Asai et al.
CANCER MEDICINE (2013)
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia
E. Waanders et al.
LEUKEMIA (2011)
Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols
Alexander N. Meleshko et al.
LEUKEMIA RESEARCH (2011)
Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial
Anthony V. Moorman et al.
LANCET ONCOLOGY (2010)
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
K. Schmiegelow et al.
LEUKEMIA (2010)
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
R. P. Kuiper et al.
LEUKEMIA (2010)
Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia
Rosemary Sutton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004)
Anjo J. Veerman et al.
LANCET ONCOLOGY (2009)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients:: results of DCLSG protocol ALL-8 (1991-1996)
WA Kamps et al.
LEUKEMIA (2002)
分享论文
